PTTG2 Inhibitors would refer to a class of chemical compounds specifically designed to suppress the activity of the PTTG2 protein. As PTTG2, also known as securin, plays a role in safeguarding the proper segregation of chromosomes during cell division, inhibitors of this protein would act to disrupt its interaction with separase or other components of the regulatory system that controls the onset of anaphase. The mode of action for these inhibitors could involve direct binding to PTTG2, preventing it from inhibiting separase, or altering the protein's stability or expression levels. The design of these inhibitors would be based on the detailed understanding of PTTG2's structure and functional domains involved in its interaction with separase and other cell cycle regulatory proteins.
The development of PTTG2 inhibitors would likely require a combination of computational and experimental methods. Structure-based drug design would be a key component, utilizing computational models to predict how small molecules might interact with PTTG2's active sites. Molecular docking simulations would help screen libraries of compounds for potential inhibitors that fit snugly within these sites. Once candidate inhibitors are identified, their efficacy would be validated through a series of in vitro and in vivo assays, assessing their ability to bind to PTTG2 and prevent its normal function. The inhibitors might work by mimicking the structure of substrates or by inducing conformational changes that negate PTTG2's ability to perform its role in the cell cycle checkpoint. The exploration of PTTG2 inhibitors would provide valuable insights into the cell cycle's intricate control mechanisms. By studying the effects of inhibiting PTTG2, researchers could gain a deeper understanding of chromosome segregation processes and the temporal regulation of the cell cycle. Furthermore, these studies could elucidate the broader role of securin proteins in cell division and stability, contributing to the fundamental knowledge of cellular biology and the dynamics of mitosis. It's important to clarify that these inhibitors would serve as tools for basic scientific research, helping to dissect the complex molecular choreography that underlies cellular proliferation and division.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
It may affect cell cycle progression and the expression of related genes by interacting with nuclear receptors. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $76.00 $255.00 | 18 | |
Can induce cell cycle arrest, potentially affecting the expression of genes involved in cell cycle control. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $40.00 $73.00 $217.00 $242.00 $724.00 $1196.00 | 39 | |
Stabilizes microtubules, causing cell cycle arrest and potentially influencing the expression of cell cycle-related genes. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $36.00 $149.00 | 11 | |
Affects DNA synthesis and cell division, which could lead to changes in the expression of cell cycle genes. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $32.00 $170.00 $385.00 | 63 | |
Causes DNA damage and can influence the expression of genes involved in DNA repair and cell cycle regulation. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $92.00 $209.00 | 33 | |
Inhibits dihydrofolate reductase, affecting DNA synthesis and potentially altering cell cycle gene expression. | ||||||
Aphidicolin | 38966-21-1 | sc-201535 sc-201535A sc-201535B | 1 mg 5 mg 25 mg | $82.00 $300.00 $1082.00 | 30 | |
Inhibits DNA polymerase, causing cell cycle arrest and possibly affecting cell cycle-related gene expression. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $92.00 $260.00 | 42 | |
A cyclin-dependent kinase inhibitor, potentially altering the expression of genes regulating cell cycle progression. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Influences cell proliferation and could modify the expression of various cell cycle-related genes. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $150.00 $286.00 $479.00 $1299.00 $8299.00 $915.00 | 22 | |
May influence cell cycle progression and the expression of associated genes through its effect on signaling pathways. | ||||||